NeuroTimone Facility (PFNT)

The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.


  1. New publication from PINT facility in Cellular and Molecular Life Sciences

    Géraldine Ferracci (Study Engineer on the PINT platform) participated in the publication entitled "Molecular landscape of BoNT/B bound to a membrane inserted synaptotagmin/ganglioside complex" which appeared on August 25, 2022 in Cellular and Molecular Life Sciences.

    Abstract :

  2. Pôle spectrométrie de masse de la plateforme PINT

    Après une période transitoire où il est resté sur le site de la faculté Nord, le spectromètre de masse de l'INP (Thermo Scientific Q-exactive) est arrivé sur le site Timone cet été. Maya Belghazi ayant quitté l'INP pour rejoindre l'IMM, Claude Villard est dorénavant votre seul interlocuteur pour les projets en lien avec cet appareil.

  3. Zinc Modulation of Neuronal Calcium Sensor Proteins: Three Modes of Interaction with Different Structural Outcomes

    Congratulation to Vika post doc in team 9 (Cytoskeleton and NeuroPhysiopathology) for this great piece of work on Zinc Modulation of 3 families of Neuronal Calcium Sensor Proteins recently published in Biomolecules.

  4. Opening of the Nikon Center of Excellence for Neuro-NanoImaging at INP

    After being postponed in 2021, the inauguration of the Nikon Center of Excellence for Neuro-Nanoimaging at Aix-Marseille Université (see more details on the Center of Excellence below) will take place on September 22, 2022 starting at 9:00 am on the Timone campus (Grisoli amphitheater), in the presence of the President of AMU Mr. Eric Berton and the Director of Nikon Europe Mr. Takaharu Sasaoka. We are pleased to invite you to this event which will combine an international scientific symposium, followed by an inauguration ceremony and the possibility to visit the platform (see attached program).

  5. Team 6 (Nivet) at NeuroMarseille's Day

    Team 6 was happy to participate in NeuroMarseille's day, which took place on June 28, 2022.

    Many members of the INP attended this scientific and friendly day for the neuroscience community. 

    Our M1 student, Marine Dos Santos, also presented her one-month work in our team, during the afternoon poster session. 

    We thank NeuroMarseille for this great day !




  6. Canceropole Annual Seminar in St Raphaël

    INP members from team 8 (GlioME: Gliomagenesis and MicroEnvironment) and team 9 (Cytoskeleton and Neurophysiopathology) attended the Canceropole PACA annual seminar which took place in Saint-Raphaël palais des congrés on July 5th and 6th 2022. 

  7. INP attending first MOSBRI meeting in Paris

    On the 20-22 nd June, the first Molecular Scale Biophysics Research Infrastructure (MOSBRI) conference was held in Paris. Dahbia Yatoui from team 9 and Géraldine Ferracci from PINT went to this event, where Dahbia had the opportunity to present her work "Role of zinc-binding sites in Tau aggregation" on a poster.

  8. Aurélie Tchoghandjian at the SunRise Congress

    The GlioME team was represented on 8 and 9 June 2022 at the Sunrise (Solid tumor cancer stem cell network) meeting at the Curie Institute in Paris. 

    Aurélie Soubéran presented a poster on the role of the ML-IAP protein in glioblastoma growth and Aurélie Tchoghandjian presented the team's work on "Smac mimetic as pan-cellular therapy in glioblastoma".


INP in numbers

  • 126 members
  • 44 researchers
  • 48 research assistants
  • 12 post-docs
  • 11 PhD


The GlioME team has obtained a "Action Structurante" funding for the creation of the PETRA facility

Emeline Tabouret and Aurélie Tchoghandjian, in collaboration with Thierry Virolle's team at the l'Institut de Biologie Valrose in Nice, are among the two winners to have obtained "Action structurante" funding from the Cancéropôle PACA.

This funding aims to structure the neuro-oncology at the preclinical and translational level in the region (between Marseille and Nice) and will be used to create the PETRA (PrEclinical and TRAnslational Research) platform on these two sites.